CytomX Therapeutics: Additional Run Up Into The Q1 2026 Readout Is Possible
Source: SeekingAlpha
2025-10-13 23:45:00 ET
...
Read the full article on Seeking Alpha
For further details see:
CytomX Therapeutics: Additional Run Up Into The Q1 2026 Readout Is Possible
CytomX Therapeutics Inc.
NASDAQ: CTMX
CTMX Trading
-1.58% G/L:
$4.675 Last:
1,737,279 Volume:
$4.90 Open:
CTMX Latest News
March 04, 2026 08:00:00 am
CytomX Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026
January 27, 2026 07:00:00 am
Cardiff Oncology Announces Executive Leadership Changes as it Transitions to Late-Stage Clinical Development
CTMX Stock Data
$945,449,504
141,817,426
0.97%
31
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
